Aerovate Therapeutics Statistics
Total Valuation
AVTE has a market cap or net worth of $77.68 million. The enterprise value is $1.78 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTE has 28.99 million shares outstanding. The number of shares has increased by 8.55% in one year.
| Current Share Class | 28.99M |
| Shares Outstanding | 28.99M |
| Shares Change (YoY) | +8.55% |
| Shares Change (QoQ) | -0.87% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 46.18% |
| Float | 11.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.01, with a Debt / Equity ratio of 0.00.
| Current Ratio | 32.01 |
| Quick Ratio | 31.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.01% and return on invested capital (ROIC) is -39.94%.
| Return on Equity (ROE) | -59.01% |
| Return on Assets (ROA) | -36.18% |
| Return on Invested Capital (ROIC) | -39.94% |
| Return on Capital Employed (ROCE) | -71.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTE has paid $55,000 in taxes.
| Income Tax | 55,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.36% in the last 52 weeks. The beta is 0.95, so AVTE's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -87.36% |
| 50-Day Moving Average | 2.53 |
| 200-Day Moving Average | 2.32 |
| Relative Strength Index (RSI) | 58.34 |
| Average Volume (20 Days) | 595,427 |
Short Selling Information
The latest short interest is 4.59 million, so 15.85% of the outstanding shares have been sold short.
| Short Interest | 4.59M |
| Short Previous Month | 4.29M |
| Short % of Shares Out | 15.85% |
| Short % of Float | 38.39% |
| Short Ratio (days to cover) | 26.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.37M |
| Pretax Income | -82.13M |
| Net Income | -48.96M |
| EBITDA | -53.11M |
| EBIT | -53.37M |
| Earnings Per Share (EPS) | -$1.70 |
Full Income StatementBalance Sheet
The company has $76.21 million in cash and $312,000 in debt, giving a net cash position of $75.90 million or $2.62 per share.
| Cash & Cash Equivalents | 76.21M |
| Total Debt | 312,000 |
| Net Cash | 75.90M |
| Net Cash Per Share | $2.62 |
| Equity (Book Value) | 75.05M |
| Book Value Per Share | 2.59 |
| Working Capital | 74.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -49.90M |
| Capital Expenditures | n/a |
| Free Cash Flow | -71.20M |
| FCF Per Share | -$2.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |